Cost of in-center vs. home HD

Home HD has better clinical and patient centered outcomes than standard in-center HD. Does it cost less, too? A systematic literature review from 2000-2014 found six relevant studies and concluded that home HD (including short daily and nocturnal) is more cost effective; higher start-up costs are recouped over the long term. In-center HD has higher staff costs and poorer outcomes.

Read the abstract » | (added 2014-05-06)

Tags:

Strict volume control on PD helps the arteries and heart

In a prospective observational study of 58 people on PD, there was no difference in echocardiogram findings between APD and CAPD. But, those who followed strict volume control had better blood pressure control, less arterial stiffness, and lower NT-pro-BNP levels (a marker of left ventricular function).

Read the abstract » | (added 2014-05-06)

Tags:

Online educational modules for professionals boost home therapies

A 3-module package of web-based e-learning about home dialysis was developed and tested on 88 undergraduate health professionals in Australia. Matching pre- and post-educational attitudes revealed clear knowledge deficits at the start, and significant improvement (p<0.001) afterward.

Read the abstract » | (added 2014-04-09)

Tags: Chronic kidney disease

High-sensitivity CRP levels predict technique and patient survival on PD

High C-reactive protein (CRP) levels suggest inflammation. Among 402 PD patients followed for 2 years, those with the lowest CRP levels were more likely to still be on PD and had better survival. Each 1 mg/L increase in CRP predicted a 1.4% higher risk of mortality.

Read the abstract » | (added 2014-04-09)

Tags:

An HbA1c mean glucose formula for PD

Glucose in PD solution changes HbA1c levels. Chinese researchers compared blood sugar and HBA1c levels of 305 people on CAPD, of whom 13 had type 1 diabetes and 161 had type 2. Using linear regression, the authors identified a formula to correct HBA1c levels for PD users.

Read the abstract » | (added 2014-04-09)

Tags:

Short daily HD may reduce phosphate burden vs. standard HD

In a small study of short daily HD users (n=24) vs. standard in-center HD users (n=54), serum calcium, serum phosphorus, and PTH levels were similar between the two groups. But, levels of fibroblast growth factor 23—which may be a marker of cumulative phosphate burden in the body—were significantly lower with short daily HD (P<0.01).

Read the abstract » | (added 2014-03-07)

Tags:

Which came first: the peritoneal glucose load index, or LVH?

Glucose load in 43 stable PD patients was calculated with a peritoneal glucose load index (PGLI) based on glucose in grams/Kg/day in the daily PD prescription. A PGLI of > 3 g/Kg/day was positively correlated both with hemoglobin A1c levels and with left ventricular mass (p<0.001). The authors conclude that safe levels for PGLI need to be studied further. But, while this seems very plausible, correlations are not causal...

Read the abstract » | (added 2014-03-07)

Tags:

Japanese strategy to prevent encapsulating peritoneal sclerosis (EPS)

EPS is a rare and severe complication of PD. Japanese clinicians offer a multidisciplinary approach to avoid EPS and improve outcomes for those who have it. Icodextrin and combination PD/HD treatment is used, and high-risk patients have planned PD stoppage. Between 2008 and 2012, the incidence of EPS was 0.3% for PD < 3 years, 0.6% for PD = 5 years, 2.3% for PD = 8 years, and 1.2% for PD > 8 years. Prednisone (n=11) and surgery (n=2) were used to treat EPS; remission occurred in 12 of the patients (85.7%), while 3 died (21.4%).

Read the abstract » | (added 2014-03-07)

Tags:

Standard HD vs. PD for risk of hip fracture

Among the 64,124 incident ESRD patients in a Taiwan registry between 1998 and 2008, 2,587 had a hip fracture. The risk of fracture was linked with sex, age, heart disease, diabetes, epilepsy drugs, diuretics, steroids, and vitamin D use. Those on standard in-center HD had a 52% higher risk of hip fracture than those on PD (p = 0.02).

Read the abstract » | (added 2014-03-07)

Tags:

Older patients on PD and health-related quality of life

In a cross-sectional study of 201 people using APD or CAPD, those over age 65 had significantly better quality of life than those under 65—though rates of anxiety and depression in both groups were similar. Age is not a reason to preclude PD.

Read the abstract » | (added 2014-03-07)

Tags: